Monday, August 26, 2019 9:49:09 PM
‘Significant outreach’
One document, dated June of 2015, outlines some of Monsanto’s lobbying strategies following the IARC’s classification of glyphosate as a carcinogen risk. The company would use “significant outreach within the US government” to shift opinion in the company’s favor.
First and foremost, the firm laid out its plan to persuade the World Health Organization (WHO) to give “clarification” on the IARC decision, effectively pressuring the organization to undermine its own finding. In doing so, the firm leveraged far-reaching connections at the Environmental Protection Agency, the Department of Agriculture, the Office of the US Trade Representative, the State Department, the Department of Health and Human Services, as well as within Congress.
Another email exchange, from later in 2015, further details Monsanto’s efforts to combat the IARC’s message, including placing pro-glyphosate ads and op-eds in US media – the company explored using a “medical doctor” to pen an article – and preparing a letter to send to lawmakers.
The company also paid consultants to draft a letter accusing the IARC of dealing in “bunk science,” which it planned to be ‘ghostwritten’ under the name of Congressman Rob Aderholt (R-AL) and addressed to the director of the National Institutes for Health (NIH), a public health research agency and the IARC’s biggest funder. In the draft letter, the congressmen would have threatened a reassessment of the NIH’ s budget if it didn’t take the proper line on glyphosate.
While Aderholt did request the NIH to review IARC’s glyphosate work in a letter that echoed some points in the ghostwritten draft, he ultimately did not use the template letter supplied by Monsanto. However, a Monsanto consultant, Todd Rands, argued during a court deposition that such ghostwriting is “common practice in Washington.”
How US regulators embrace toxic pesticides & the corporations that make them
Other lawmakers also worked in tandem with the company’s IARC counter-campaign, including congressmen Jason Chaffetz (R-UT), Trey Gowdy (R-SC) and Lamar Smith (R-TX, now retired), and the firm coordinated closely with Republican members of congressional committees, such as the Oversight and Science panels.
In 2018, Smith, as chair of the House Science Committee, devoted an entire committee meeting to questioning the IARC, particularly on the issue of glyphosate, and later sent letters to researchers in Norway demanding they “correct the flaws in IARC.”
A second set of recently published litigation records also revealed that Monsanto contracted with corporate intelligence outfit Hakluyt to observe and confer with Washington lawmakers, perhaps worried some may break ranks. Reassuring the firm, a White House policy adviser told Hakluyt. “We have Monsanto’s back on pesticide regulation” and that “Monsanto need not fear any additional regulation from this administration.”
Silencing the critics
Yet another trove of documents obtained by The Guardian earlier this month, however, shows that Monsanto went far beyond lobbying congress and other government agencies. In its efforts to combat reporting on the dangers of glyphosate, the company created a “fusion center” to monitor journalists and activists, and developed a “multi-pronged” strategy to smear inconvenient critics.
Austria becomes first EU country to ban glyphosate weedkiller
In one case, the firm distributed “talking points” to “third parties” in order to counter reporter Carey Gillam’s 2017 book – ’Whitewash: The Story of a Weed Killer, Cancer, and the Corruption of Science’ – and instructed “industry and farmer customers” on how to leave negative reviews on her work. The company maintained a “Carey Gillam Book” spreadsheet which detailed over 20 separate “actions” devoted to tarnishing the work before its publication.
Monsanto also paid Google to promote search results critical of Gillam’s book, while staff at the company discussed putting pressure on the reporter’s editors, hoping to get her “reassigned.”
“I’ve always known that Monsanto didn’t like my work … and worked to pressure editors and silence me, but I never imagined a multi-billion dollar company would actually spend so much time and energy and personnel on me,” Gillam told The Guardian. “It’s astonishing.”
The so-called fusion center also closely tracked other activists, including the Twitter activity of musician Neil Young, a longtime critic of the agri-giant, and even “evaluated the lyrics” on one of his albums to develop “a list of 20+ potential topics he may target.”
Despite the growing body of research indicating that glyphosate poses health risks, and a number of court settlements rewarding plaintiffs alleging the same, Roundup in its current form remains legal in the United States. As long as Monsanto ghostwrites scientific research with its own bottom line in mind, and keeps former lawmakers – such as Lamar Smith – on retainer as lobbyists, it just might stay that way.
Recent BAYRY News
- Bayer Names Nelson Ambrogio as New Head of Radiology Business • Dow Jones News • 01/22/2024 02:26:00 PM
- Bayer's Menopause Drug Elinzanetant Met Primary Endpoints in Phase 3 Studies • Dow Jones News • 01/08/2024 08:05:00 AM
- Bayer's Monsanto Ordered to Pay $857 Million Over Chemicals in Washington State School, Bloomberg Reports • Dow Jones News • 12/19/2023 10:12:00 AM
- Trending: Bayer Shares Tank After Key Clinical Trial Halted Early, Roundup Verdict • Dow Jones News • 11/20/2023 03:43:00 PM
- Bayer Shares Tumble After Clinical Trial Failure, Roundup Case Loss • Dow Jones News • 11/20/2023 10:20:00 AM
- Bayer Stops Late-Stage Study for Stroke Prevention Due to Lack of Efficacy • Dow Jones News • 11/20/2023 07:22:00 AM
- Bayer Pulling Lymphoma Drug Aliqopa From U.S. • Dow Jones News • 11/13/2023 03:58:00 PM
- Bayer Gets CHMP Backing for Higher-Dose Eylea in Two Major Retinal Eye Diseases • Dow Jones News • 11/10/2023 03:00:00 PM
- Bayer Weighs Structural Changes But Rules Out Three-Way Split -- 3rd Update • Dow Jones News • 11/08/2023 10:32:00 AM
- Bayer Weighs Structural Changes But Rules Out Three-Way Split -- 2nd Update • Dow Jones News • 11/08/2023 08:40:00 AM
- Bayer Considers Structural Changes But Rules Out Three-Way Split -- Update • Dow Jones News • 11/08/2023 07:41:00 AM
- Bayer Looks at Options to Overhaul Structure • Dow Jones News • 11/08/2023 07:17:00 AM
- Bayer Launches New Rice Cultivation Method it Says Can Cut Emissions by 45% -- OPIS • Dow Jones News • 10/16/2023 10:03:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM